nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Autoimmune aspects of psoriasis: Heritability and autoantigens
|
Prinz, Jörg Christoph |
|
2017 |
16 |
9 |
p. 970-979 10 p. |
artikel |
2 |
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases
|
Li, You |
|
2017 |
16 |
9 |
p. 885-896 12 p. |
artikel |
3 |
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
|
Mekinian, Arsene |
|
2017 |
16 |
9 |
p. 903-910 8 p. |
artikel |
4 |
Biomarkers of disease activity in vitiligo: A systematic review
|
Speeckaert, R. |
|
2017 |
16 |
9 |
p. 937-945 9 p. |
artikel |
5 |
Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature
|
André, Raphaël |
|
2017 |
16 |
9 |
p. 963-969 7 p. |
artikel |
6 |
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis
|
Ferrari, Silvia Martina |
|
2017 |
16 |
9 |
p. 946-950 5 p. |
artikel |
7 |
Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes
|
Yılmaz, İnsu |
|
2017 |
16 |
9 |
p. 992-993 2 p. |
artikel |
8 |
Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP
|
Izmirly, Peter M. |
|
2017 |
16 |
9 |
p. 980-983 4 p. |
artikel |
9 |
Does type-I interferon drive systemic autoimmunity?
|
Picard, Cécile |
|
2017 |
16 |
9 |
p. 897-902 6 p. |
artikel |
10 |
Effects of Interleukin 17 on the cardiovascular system
|
Robert, Marie |
|
2017 |
16 |
9 |
p. 984-991 8 p. |
artikel |
11 |
Endothelial cells: From innocent bystanders to active participants in immune responses
|
Al-Soudi, A. |
|
2017 |
16 |
9 |
p. 951-962 12 p. |
artikel |
12 |
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?
|
Giacomelli, Roberto |
|
2017 |
16 |
9 |
p. 911-924 14 p. |
artikel |
13 |
Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions
|
Patejdl, Robert |
|
2017 |
16 |
9 |
p. 925-936 12 p. |
artikel |